Microorganism |
MIC50 (μg/ml) |
MIC90 (μg/ml) |
Range (μg/ml) |
Antimicrobial |
Reference |
Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
4 |
0.125 - 16 |
Linezolid (PNU-100766, U-100766, Zyvox) |
1464 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
≤0.12 - 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
371 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
1 - 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
73 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
1 - 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
207 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
1 - 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
72 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
- |
1.5 |
? - ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
1112 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
- |
2 |
? - ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
1358 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
- |
- |
0.5 - 1 |
Linezolid (PNU-100766, U-100766, Zyvox) |
280 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
- |
- |
0.5 - 1 |
Linezolid (PNU-100766, U-100766, Zyvox) |
193 |